Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Feline Med Surg ; 21(4): 306-313, 2019 04.
Article in English | MEDLINE | ID: mdl-29788830

ABSTRACT

OBJECTIVES: The main aim of the study was to establish response, disease-free interval (DFI) and overall survival of cats with nasal planum squamous cell carcinoma (SCC) treated with Sr90 plesiotherapy. A secondary aim was to determine whether a fractionated protocol is more effective than a single-dose protocol in terms of response, DFI and overall survival. The third aim was to evaluate whether we can identify prognostic factors that influence overall survival. METHODS: This was a retrospective study that included cats with a diagnosis of nasal planum SCC treated with Sr90 plesiotherapy at a single institution. RESULTS: Seventy-four cats were included in the study. Thirty-two were treated with a fractionated protocol and 42 with a single-dose treatment. Sr90 plesiotherapy was able to induce complete response in 74% of cats with nasal planum SCC. The median DFI was 780 days (95% confidence interval [CI] 383-1177), with 17% of cats experiencing local recurrence. The overall survival for all cats was 1039 days (95% CI 55-1528). The DFI of cats treated with the fractionated Sr90 was significantly longer compared with the single-dose treatment, whereas response and overall survival were not statistically different. Other prognostic factors that influenced the overall survival were early-stage disease, absence of concurrent problems and complete response to the treatment. Acute and long-term toxicity associated with the treatment were minimal and the aesthetic outcome was pleasing in almost all cases. CONCLUSIONS AND RELEVANCE: Strontium plesiotherapy is a safe and effective treatment of nasal planum SCC in cats.


Subject(s)
Carcinoma, Squamous Cell , Cat Diseases , Dose Fractionation, Radiation , Nose Neoplasms , Strontium Radioisotopes/therapeutic use , Animals , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/radiotherapy , Carcinoma, Squamous Cell/veterinary , Cat Diseases/mortality , Cat Diseases/radiotherapy , Cats , Disease-Free Survival , Nose Neoplasms/mortality , Nose Neoplasms/radiotherapy , Nose Neoplasms/veterinary , Retrospective Studies
2.
PLoS One ; 10(6): e0127800, 2015.
Article in English | MEDLINE | ID: mdl-26068641

ABSTRACT

INTRODUCTION: 2-Deoxy-2-[18F]fluoro-D-glucose PET/CT is a well-established imaging method for staging, restaging and therapy-control in human medicine. In veterinary medicine, this imaging method could prove to be an attractive and innovative alternative to conventional imaging in order to improve staging and restaging. The aim of this study was both to evaluate the effectiveness of this image-guided method in canine patients with spontaneously occurring cancer as well as to illustrate the dog as a well-suited animal model for comparative oncology. METHODS: Ten dogs with various malignant tumors were included in the study and underwent a whole body FDG PET/CT. One patient has a second PET-CT 5 months after the first study. Patients were diagnosed with histiocytic sarcoma (n = 1), malignant lymphoma (n = 2), mammary carcinoma (n = 4), sertoli cell tumor (n = 1), gastrointestinal stromal tumor (GIST) (n = 1) and lung tumor (n = 1). PET/CT data were analyzed with the help of a 5-point scale in consideration of the patients' medical histories. RESULTS: In seven of the ten dogs, the treatment protocol and prognosis were significantly changed due to the results of FDG PET/CT. In the patients with lymphoma (n = 2) tumor extent could be defined on PET/CT because of increased FDG uptake in multiple lymph nodes. This led to the recommendation for a therapeutic polychemotherapy as a treatment. In one of the dogs with mammary carcinoma (n = 4) and in the patient with the lung tumor (n = 1), surgery was cancelled due to the discovery of multiple metastasis. Consequently no treatment was recommended. CONCLUSION: FDG PET/CT offers additional information in canine patients with malignant disease with a potential improvement of staging and restaging. The encouraging data of this clinical study highlights the possibility to further improve innovative diagnostic and staging methods with regard to comparative oncology. In the future, performing PET/CT not only for staging but also in therapy control could offer a significant improvement in the management of dogs with malignant tumors.


Subject(s)
Dog Diseases/diagnosis , Dog Diseases/pathology , Fluorodeoxyglucose F18 , Neoplasms/veterinary , Positron-Emission Tomography , Tomography, X-Ray Computed , Animals , Disease Models, Animal , Dogs , Female , Male
3.
Berl Munch Tierarztl Wochenschr ; 123(1-2): 42-8, 2010.
Article in English | MEDLINE | ID: mdl-20135909

ABSTRACT

In this prospective study performed from samples of 296 cats from Southern Bavaria, Germany, a conventional PCR (polymerase chain reaction) assay for detection of Mycoplasma haemofelis and "Candidatus Mycoplasma haemominutum" and a real-time PCR for "Candidatus Mycoplasma turicensis" were used to test blood samples from ill cats with anaemia (n = 79), ill cats with a normal haematocrit (n = 98), and healthy cats (n = 119). The aim of the study was to investigate the prevalence of feline haemoplasma infection and associated risk factors in cats in Southern Bavaria, Germany. Thirty-six cats (12.2%) were PCR positive: 9.5% were infected with "Candidatus M. haemominutum, 1.4% with M. haemofelis, and 0.3% with "Candidatus M. turicensis". Three cats (1.0%) were coinfected with two haemoplasma species (one cat with "Candidatus M. haemominutum"and M. haemofelis, and two cats with "Candidatus M. haemominutum"and "Candidatus M. turicensis"). Risk factors for infection were outdoor access, male gender, coinfection with feline leukaemia virus (FeLV), and domestic shorthair breed. There was no significant difference in the prevalence of haemoplasma infection between the three groups and none of the positive cats had clinical signs of haemoplasma infection. The authors conclude that feline haemoplasma infection does not appear to be a common cause of anaemia in cats in Southern Bavaria, Germany.


Subject(s)
Cat Diseases/epidemiology , Mycoplasma Infections/veterinary , Animals , Cats , Female , Germany/epidemiology , Health Status , Male , Mycoplasma/genetics , Mycoplasma/isolation & purification , Mycoplasma Infections/epidemiology , Polymerase Chain Reaction , Prevalence , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...